NORMAL SITUATION

PHARMAREVES

Export PDF

Financial year 2023 · closed on 31/12/2023

Net result

153,3 k €

+326.5% YoY

Gross margin

199,4 k €

+2248.5% YoY

Equity

54,3 k €

+154.9% YoY

Company — Normal situation.

What does PHARMAREVES do?

PHARMAREVES is a company registered in Belgium.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0860.383.466

Legal form

Private limited company

Contributed capital

6 200,00 €

Latest accounts

31/12/2023

Joint committees (1)

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	199,4 k €	+2248%	8,5 k €	-84.7%	55,6 k €	-32.3%	82,2 k €	-5.8%	87,2 k €	+5.2%	82,9 k €	-28.3%	115,6 k €	-2.1%	118 k €	+14.0%	103,5 k €	-8.5%	113,1 k €	+23.2%	91,8 k €	+13.4%	80,9 k €	+3.7%	78 k €	-3.1%	80,5 k €	-1.8%	82 k €	-4.3%	85,7 k €
EBITDA	185,2 k €	+640%	-34,3 k €	-251%	22,7 k €	-34.9%	34,9 k €	+65.5%	21,1 k €	-18.9%	26 k €	-26.2%	35,2 k €	-12.3%	40,2 k €	+13.0%	35,5 k €	-38.5%	57,8 k €	+1.3%	57 k €	+11.3%	51,2 k €	+9.4%	46,8 k €	-10.2%	52,2 k €	-8.1%	56,8 k €	+36.1%	41,7 k €
Operating result	185,1 k €	+559%	-40,3 k €	-361%	15,4 k €	-50.6%	31,2 k €	+88.6%	16,5 k €	-8.1%	18 k €	-23.7%	23,6 k €	-9.0%	25,9 k €	+188%	9 k €	-46.8%	16,9 k €	+12.8%	15 k €	+7.4%	13,9 k €	+103%	6,9 k €	-35.9%	10,7 k €	-33.0%	16 k €	+149%	6,4 k €
Net result	153,3 k €	+326%	-67,7 k €	-7581%	-881,5 €	-105%	17,2 k €	+29.7%	13,2 k €	+10.2%	12 k €	+137%	-32,2 k €	-330%	14 k €	+2424%	555 €	-91.5%	6,5 k €	+353%	1,4 k €	+581%	212 €	+104%	-5,9 k €	-67.9%	-3,5 k €	-87900%	4 €	+100%	-11,4 k €
Balance sheet
Equity	54,3 k €	+155%	-99 k €	-216%	-31,3 k €	-180%	39,2 k €	+78.1%	22 k €	+151%	8,8 k €	+369%	-3,3 k €	-111%	28,9 k €	+94.0%	14,9 k €	+3.9%	14,3 k €	+83.9%	7,8 k €	+22.7%	6,4 k €	+3.4%	6,1 k €	-49.0%	12 k €	-22.6%	15,6 k €	+0.0%	15,6 k €
Total assets	99,5 k €	+4.4%	95,3 k €	-28.5%	133,3 k €	-31.8%	195,5 k €	+14.7%	170,4 k €	+5.9%	160,8 k €	-26.7%	219,3 k €	+23.0%	178,3 k €	-4.9%	187,5 k €	-21.6%	239,1 k €	-16.4%	286,1 k €	-10.0%	317,9 k €	+0.7%	315,6 k €	+0.3%	314,7 k €	-7.4%	340 k €	-9.5%	375,8 k €
Cash	44 k €	+1103%	3,7 k €	-0.2%	3,7 k €	-83.4%	22 k €	+199%	7,4 k €	-17.0%	8,9 k €	-70.1%	29,7 k €	-1.1%	30 k €	-33.9%	45,4 k €	+12.2%	40,4 k €	-30.6%	58,2 k €	+31.9%	44,2 k €	+88.5%	23,4 k €	+18.9%	19,7 k €	+15.4%	17,1 k €	+20.6%	14,2 k €
Debts	45,1 k €	-76.7%	193,5 k €	+18.1%	163,9 k €	+4.9%	156,3 k €	+5.5%	148,1 k €	-2.5%	152 k €	-31.7%	222,5 k €	+49.0%	149,4 k €	-13.5%	172,6 k €	-23.2%	224,8 k €	-12.5%	257 k €	-17.5%	311,6 k €	+0.7%	309,5 k €	+2.2%	302,7 k €	-6.7%	324,4 k €	-7.9%	352,2 k €
Other
Workforce	–		–		–		–		–		–		2,3 ETP	+15.0%	2,0 ETP	0.0%	2,0 ETP	-4.8%	2,1 ETP	+75.0%	1,2 ETP	+20.0%	1,0 ETP	-9.1%	1,1 ETP	+10.0%	1,0 ETP	0.0%	1,0 ETP	-16.7%	1,2 ETP

Governance

Board of directors

Seen on filing of 31/12/2023 · 1 active · 3 ended

Active mandates

Marjorie Turkelboom

Director

Active

Ended mandates

Marjorie Turkelboom

Director · since 05 mars 2021

Ended

Marjorie Turkelboom

Director · since 20 mai 2003

Ended

Marjorie TURKELBOOM

Manager

Ended

Annual accounts

Full financial information

	2023	2022	2021	2020	2019	2018
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019	01/01/2018
Closing of the financial year	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019	31/12/2018
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	06/06/2024	06/03/2023	27/07/2022	11/06/2021	02/06/2020	19/06/2019
General meeting	25/05/2024	20/02/2023	28/05/2022	29/05/2021	30/05/2020	25/05/2019
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2023	25/05/2024	06/06/2024	French	PDF
Micro model	31/12/2022	20/02/2023	06/03/2023	French	PDF
Micro model	31/12/2021	28/05/2022	27/07/2022	French	PDF
Micro model	31/12/2020	29/05/2021	11/06/2021	French	PDF
Micro model	31/12/2019	30/05/2020	02/06/2020	French	PDF
Micro model	31/12/2018	25/05/2019	19/06/2019	French	PDF
Micro model	31/12/2017	26/05/2018	28/05/2018	French	PDF
Micro model	31/12/2016	27/05/2017	13/06/2017	French	PDF
Abridged model	31/12/2015	28/05/2016	17/06/2016	French	PDF
Abridged model	31/12/2014	30/05/2015	02/07/2015	French	PDF
Abridged model	31/12/2013	24/05/2014	09/07/2014	French	PDF
Abridged model	31/12/2012	25/05/2013	24/07/2013	French	PDF
Abridged model	31/12/2011	26/05/2012	24/08/2012	French	PDF
Abridged model	31/12/2010	28/05/2011	31/08/2011	French	PDF
Abridged model	31/12/2009	29/05/2010	14/07/2010	French	PDF
Abridged model	31/12/2008	30/05/2009	27/08/2009	French	PDF
Abridged model	31/12/2007	31/05/2008	28/08/2008	French	PDF
Abridged model	31/12/2006	26/05/2007	03/08/2007	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2023 · 1 active · 3 ended

Active mandates

Marjorie Turkelboom

Director

Active

Ended mandates

Marjorie Turkelboom

Director · since 05 mars 2021

Ended

Marjorie Turkelboom

Director · since 20 mai 2003

Ended

Marjorie TURKELBOOM

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Dissolution21/08/2024
RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
PDF
Registered office19/12/2023
SIEGE SOCIAL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2023
Annual accounts 2023153,3 k €↑
2022
Annual accounts 2022-67,7 k €↓
2021
Annual accounts 2021-881,5 €↓
2018
Annual accounts 201817,2 k €↑
2017
Annual accounts 201713,2 k €↑
2016
Annual accounts 201612 k €↑
2015
Annual accounts 2015-32,2 k €↓
2014
Annual accounts 201414 k €↑
2013
Annual accounts 2013555 €↓
2012
Annual accounts 20126,5 k €↑
2011
Annual accounts 20111,4 k €↑
2010
Annual accounts 2010212 €↑
2009
Annual accounts 2009-5,9 k €↓
2008
Annual accounts 2008-3,5 k €↓
2007
Annual accounts 20074 €↑
2006
Annual accounts 2006-11,4 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMAREVES

Overview

What does PHARMAREVES do?

Trend over 16 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline